91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Artificial Vital Organs Market Research Report 2024

Global Artificial Vital Organs Market Research Report 2024

Publication ID: 
PB504247628
Publication Date: 
April 29, 2024
Pages: 
104
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

Artificial organ is man-made machine or device that is used to replace the functions of missing or faulty organ and restores the functions of original organ.
The global Artificial Vital Organs market was valued at US$ 26020 million in 2023 and is anticipated to reach US$ 47130 million by 2030, witnessing a CAGR of 8.7% during the forecast period 2024-2030.
Increasing organ failure and disability due to age-related disorders, new and modified technologies, increasing accidents and injuries leading to organ deletion, rise in number of people awaiting organ transplants and lack of donors are the major drivers responsible for the growth of this market.
This report aims to provide a comprehensive presentation of the global market for Artificial Vital Organs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Vital Organs.
Report Scope
The Artificial Vital Organs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Vital Organs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Vital Organs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Edwards Lifesciences Corporation
Abbott Diabetes Care
Baxter International
Ekso Bionics
Asahi Kasei Medical
Jarvik Heart
Ottobock Healthcare
Abiomed Inc
Boston Scientific Corporation
Ossur
Medtronic
Zimmer Biomet
Heartware International, Inc
SynCardia Systems, LLC.
Iwalk, Inc.
Berlin Heart Gmbh
Biomet, Inc
CARMAT
Cleveland Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Fresenius Medical Care AG & Co. KGaA
Cyberonics, Inc
F. Hoffmann-La Roche Ltd
BiVACOR
Segment by Type
Artificial Liver
Artificial Heart
Artificial Pancreas
Artificial Kidney
Artificial Lungs
Others
Segment by Application
Hospitals
Clinics
Research Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Vital Organs companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Vital Organs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Artificial Liver
1.2.3 Artificial Heart
1.2.4 Artificial Pancreas
1.2.5 Artificial Kidney
1.2.6 Artificial Lungs
1.2.7 Others
1.3 Market by Application
1.3.1 Global Artificial Vital Organs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Vital Organs Market Perspective (2019-2030)
2.2 Artificial Vital Organs Growth Trends by Region
2.2.1 Global Artificial Vital Organs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Vital Organs Historic Market Size by Region (2019-2024)
2.2.3 Artificial Vital Organs Forecasted Market Size by Region (2025-2030)
2.3 Artificial Vital Organs Market Dynamics
2.3.1 Artificial Vital Organs Industry Trends
2.3.2 Artificial Vital Organs Market Drivers
2.3.3 Artificial Vital Organs Market Challenges
2.3.4 Artificial Vital Organs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Vital Organs Players by Revenue
3.1.1 Global Top Artificial Vital Organs Players by Revenue (2019-2024)
3.1.2 Global Artificial Vital Organs Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Vital Organs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Vital Organs Revenue
3.4 Global Artificial Vital Organs Market Concentration Ratio
3.4.1 Global Artificial Vital Organs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Vital Organs Revenue in 2023
3.5 Artificial Vital Organs Key Players Head office and Area Served
3.6 Key Players Artificial Vital Organs Product Solution and Service
3.7 Date of Enter into Artificial Vital Organs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Vital Organs Breakdown Data by Type
4.1 Global Artificial Vital Organs Historic Market Size by Type (2019-2024)
4.2 Global Artificial Vital Organs Forecasted Market Size by Type (2025-2030)
5 Artificial Vital Organs Breakdown Data by Application
5.1 Global Artificial Vital Organs Historic Market Size by Application (2019-2024)
5.2 Global Artificial Vital Organs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Vital Organs Market Size (2019-2030)
6.2 North America Artificial Vital Organs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Vital Organs Market Size by Country (2019-2024)
6.4 North America Artificial Vital Organs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Vital Organs Market Size (2019-2030)
7.2 Europe Artificial Vital Organs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Vital Organs Market Size by Country (2019-2024)
7.4 Europe Artificial Vital Organs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Vital Organs Market Size (2019-2030)
8.2 Asia-Pacific Artificial Vital Organs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Vital Organs Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Vital Organs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Vital Organs Market Size (2019-2030)
9.2 Latin America Artificial Vital Organs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Vital Organs Market Size by Country (2019-2024)
9.4 Latin America Artificial Vital Organs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Vital Organs Market Size (2019-2030)
10.2 Middle East & Africa Artificial Vital Organs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Vital Organs Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Vital Organs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Edwards Lifesciences Corporation
11.1.1 Edwards Lifesciences Corporation Company Detail
11.1.2 Edwards Lifesciences Corporation Business Overview
11.1.3 Edwards Lifesciences Corporation Artificial Vital Organs Introduction
11.1.4 Edwards Lifesciences Corporation Revenue in Artificial Vital Organs Business (2019-2024)
11.1.5 Edwards Lifesciences Corporation Recent Development
11.2 Abbott Diabetes Care
11.2.1 Abbott Diabetes Care Company Detail
11.2.2 Abbott Diabetes Care Business Overview
11.2.3 Abbott Diabetes Care Artificial Vital Organs Introduction
11.2.4 Abbott Diabetes Care Revenue in Artificial Vital Organs Business (2019-2024)
11.2.5 Abbott Diabetes Care Recent Development
11.3 Baxter International
11.3.1 Baxter International Company Detail
11.3.2 Baxter International Business Overview
11.3.3 Baxter International Artificial Vital Organs Introduction
11.3.4 Baxter International Revenue in Artificial Vital Organs Business (2019-2024)
11.3.5 Baxter International Recent Development
11.4 Ekso Bionics
11.4.1 Ekso Bionics Company Detail
11.4.2 Ekso Bionics Business Overview
11.4.3 Ekso Bionics Artificial Vital Organs Introduction
11.4.4 Ekso Bionics Revenue in Artificial Vital Organs Business (2019-2024)
11.4.5 Ekso Bionics Recent Development
11.5 Asahi Kasei Medical
11.5.1 Asahi Kasei Medical Company Detail
11.5.2 Asahi Kasei Medical Business Overview
11.5.3 Asahi Kasei Medical Artificial Vital Organs Introduction
11.5.4 Asahi Kasei Medical Revenue in Artificial Vital Organs Business (2019-2024)
11.5.5 Asahi Kasei Medical Recent Development
11.6 Jarvik Heart
11.6.1 Jarvik Heart Company Detail
11.6.2 Jarvik Heart Business Overview
11.6.3 Jarvik Heart Artificial Vital Organs Introduction
11.6.4 Jarvik Heart Revenue in Artificial Vital Organs Business (2019-2024)
11.6.5 Jarvik Heart Recent Development
11.7 Ottobock Healthcare
11.7.1 Ottobock Healthcare Company Detail
11.7.2 Ottobock Healthcare Business Overview
11.7.3 Ottobock Healthcare Artificial Vital Organs Introduction
11.7.4 Ottobock Healthcare Revenue in Artificial Vital Organs Business (2019-2024)
11.7.5 Ottobock Healthcare Recent Development
11.8 Abiomed Inc
11.8.1 Abiomed Inc Company Detail
11.8.2 Abiomed Inc Business Overview
11.8.3 Abiomed Inc Artificial Vital Organs Introduction
11.8.4 Abiomed Inc Revenue in Artificial Vital Organs Business (2019-2024)
11.8.5 Abiomed Inc Recent Development
11.9 Boston Scientific Corporation
11.9.1 Boston Scientific Corporation Company Detail
11.9.2 Boston Scientific Corporation Business Overview
11.9.3 Boston Scientific Corporation Artificial Vital Organs Introduction
11.9.4 Boston Scientific Corporation Revenue in Artificial Vital Organs Business (2019-2024)
11.9.5 Boston Scientific Corporation Recent Development
11.10 Ossur
11.10.1 Ossur Company Detail
11.10.2 Ossur Business Overview
11.10.3 Ossur Artificial Vital Organs Introduction
11.10.4 Ossur Revenue in Artificial Vital Organs Business (2019-2024)
11.10.5 Ossur Recent Development
11.11 Medtronic
11.11.1 Medtronic Company Detail
11.11.2 Medtronic Business Overview
11.11.3 Medtronic Artificial Vital Organs Introduction
11.11.4 Medtronic Revenue in Artificial Vital Organs Business (2019-2024)
11.11.5 Medtronic Recent Development
11.12 Zimmer Biomet
11.12.1 Zimmer Biomet Company Detail
11.12.2 Zimmer Biomet Business Overview
11.12.3 Zimmer Biomet Artificial Vital Organs Introduction
11.12.4 Zimmer Biomet Revenue in Artificial Vital Organs Business (2019-2024)
11.12.5 Zimmer Biomet Recent Development
11.13 Heartware International, Inc
11.13.1 Heartware International, Inc Company Detail
11.13.2 Heartware International, Inc Business Overview
11.13.3 Heartware International, Inc Artificial Vital Organs Introduction
11.13.4 Heartware International, Inc Revenue in Artificial Vital Organs Business (2019-2024)
11.13.5 Heartware International, Inc Recent Development
11.14 SynCardia Systems, LLC.
11.14.1 SynCardia Systems, LLC. Company Detail
11.14.2 SynCardia Systems, LLC. Business Overview
11.14.3 SynCardia Systems, LLC. Artificial Vital Organs Introduction
11.14.4 SynCardia Systems, LLC. Revenue in Artificial Vital Organs Business (2019-2024)
11.14.5 SynCardia Systems, LLC. Recent Development
11.15 Iwalk, Inc.
11.15.1 Iwalk, Inc. Company Detail
11.15.2 Iwalk, Inc. Business Overview
11.15.3 Iwalk, Inc. Artificial Vital Organs Introduction
11.15.4 Iwalk, Inc. Revenue in Artificial Vital Organs Business (2019-2024)
11.15.5 Iwalk, Inc. Recent Development
11.16 Berlin Heart Gmbh
11.16.1 Berlin Heart Gmbh Company Detail
11.16.2 Berlin Heart Gmbh Business Overview
11.16.3 Berlin Heart Gmbh Artificial Vital Organs Introduction
11.16.4 Berlin Heart Gmbh Revenue in Artificial Vital Organs Business (2019-2024)
11.16.5 Berlin Heart Gmbh Recent Development
11.17 Biomet, Inc
11.17.1 Biomet, Inc Company Detail
11.17.2 Biomet, Inc Business Overview
11.17.3 Biomet, Inc Artificial Vital Organs Introduction
11.17.4 Biomet, Inc Revenue in Artificial Vital Organs Business (2019-2024)
11.17.5 Biomet, Inc Recent Development
11.18 CARMAT
11.18.1 CARMAT Company Detail
11.18.2 CARMAT Business Overview
11.18.3 CARMAT Artificial Vital Organs Introduction
11.18.4 CARMAT Revenue in Artificial Vital Organs Business (2019-2024)
11.18.5 CARMAT Recent Development
11.19 Cleveland Heart
11.19.1 Cleveland Heart Company Detail
11.19.2 Cleveland Heart Business Overview
11.19.3 Cleveland Heart Artificial Vital Organs Introduction
11.19.4 Cleveland Heart Revenue in Artificial Vital Organs Business (2019-2024)
11.19.5 Cleveland Heart Recent Development
11.20 MyLVAD
11.20.1 MyLVAD Company Detail
11.20.2 MyLVAD Business Overview
11.20.3 MyLVAD Artificial Vital Organs Introduction
11.20.4 MyLVAD Revenue in Artificial Vital Organs Business (2019-2024)
11.20.5 MyLVAD Recent Development
11.21 Cirtec Medical Systems
11.21.1 Cirtec Medical Systems Company Detail
11.21.2 Cirtec Medical Systems Business Overview
11.21.3 Cirtec Medical Systems Artificial Vital Organs Introduction
11.21.4 Cirtec Medical Systems Revenue in Artificial Vital Organs Business (2019-2024)
11.21.5 Cirtec Medical Systems Recent Development
11.22 Thoratec Corporation
11.22.1 Thoratec Corporation Company Detail
11.22.2 Thoratec Corporation Business Overview
11.22.3 Thoratec Corporation Artificial Vital Organs Introduction
11.22.4 Thoratec Corporation Revenue in Artificial Vital Organs Business (2019-2024)
11.22.5 Thoratec Corporation Recent Development
11.23 Fresenius Medical Care AG & Co. KGaA
11.23.1 Fresenius Medical Care AG & Co. KGaA Company Detail
11.23.2 Fresenius Medical Care AG & Co. KGaA Business Overview
11.23.3 Fresenius Medical Care AG & Co. KGaA Artificial Vital Organs Introduction
11.23.4 Fresenius Medical Care AG & Co. KGaA Revenue in Artificial Vital Organs Business (2019-2024)
11.23.5 Fresenius Medical Care AG & Co. KGaA Recent Development
11.24 Cyberonics, Inc
11.24.1 Cyberonics, Inc Company Detail
11.24.2 Cyberonics, Inc Business Overview
11.24.3 Cyberonics, Inc Artificial Vital Organs Introduction
11.24.4 Cyberonics, Inc Revenue in Artificial Vital Organs Business (2019-2024)
11.24.5 Cyberonics, Inc Recent Development
11.25 F. Hoffmann-La Roche Ltd
11.25.1 F. Hoffmann-La Roche Ltd Company Detail
11.25.2 F. Hoffmann-La Roche Ltd Business Overview
11.25.3 F. Hoffmann-La Roche Ltd Artificial Vital Organs Introduction
11.25.4 F. Hoffmann-La Roche Ltd Revenue in Artificial Vital Organs Business (2019-2024)
11.25.5 F. Hoffmann-La Roche Ltd Recent Development
11.26 BiVACOR
11.26.1 BiVACOR Company Detail
11.26.2 BiVACOR Business Overview
11.26.3 BiVACOR Artificial Vital Organs Introduction
11.26.4 BiVACOR Revenue in Artificial Vital Organs Business (2019-2024)
11.26.5 BiVACOR Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned: 

Edwards Lifesciences Corporation
Abbott Diabetes Care
Baxter International
Ekso Bionics
Asahi Kasei Medical
Jarvik Heart
Ottobock Healthcare
Abiomed Inc
Boston Scientific Corporation
Ossur
Medtronic
Zimmer Biomet
Heartware International, Inc
SynCardia Systems, LLC.
Iwalk, Inc.
Berlin Heart Gmbh
Biomet, Inc
CARMAT
Cleveland Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Fresenius Medical Care AG & Co. KGaA
Cyberonics, Inc
F. Hoffmann-La Roche Ltd
BiVACOR

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-artificial-vital-organs-market-research-report-2024

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare